Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.445
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Interim Management Statement

13 Nov 2008 07:00

RNS Number : 0616I
Commercial Intnl Bank (Egypt) SAE
12 November 2008
 



CIB has released today its third quarter results with managements' following comments:

CIB enjoyed another successful quarter in Q3 and delivered strong financial and operational performance despite the challenging market conditions. This was achieved through significant growth across all business lines. In fact, the nine months results reflect CIB's continued focus to deliver consistent and sustainable performance year on year. It also reflects the hard work, commitment and diligence of all CIB employees.

Profitability

On a consolidated basis, CIB and CICH achieved EGP 2,543 million and EGP 1,274 million of Net Operating Income and Net Profit After Tax (NPAT) respectively for YTD 2008. The Bank, on a stand-alone basis, achieved an NPAT for YTD 2008 of EGP 1,282 million, up by 41.6% as compared to the same period of 2007. Regarding the period from July 1st to September 30th, 2008, NPAT reached EGP 343 million, up by 27.1% over same period in 2007, compared to 18.9% growth for Q3 2007 Vs Q3 2006.
CIB has acquired the remaining 50% stake in CICH, which is currently its wholly owned subsidiary. Accordingly, the Bank started to focus on measured growth in CICH, keeping in view the current market conditions. It is worth noting that CICH has realized NPAT of EGP 52 million during the first nine months of 2008. However, for the financials consolidation purposes, and after eliminating the intercompany transactions , CIB's consolidated NPAT was reduced by 8 million.
As highlighted in the first two quarters the NPAT comprises EGP 145 million that represents sale of a subsidiary (Contact) and provisions write backAdditionally, revenues include EGP 160 million of capital-gains mainly attributed to exit from available for sale investments. Furthermore, the exit capital-gains were previously planned- for and fall within the yearly targets of our internal private equity business.
On a stand-alone basis, Net Operating income marked EGP 2,477 million, an outstanding surge of 46over the same period of last year. This was achieved on the back of a 51% increase in net interest resulting from a high quality loan portfolio and solid ALM. Moreover, banking fees and commissions also showed a steady growth of 24over the same period of last year and Foreign exchange profits impressively surged up by 99% over same period, due to higher customer volumes.
Return on Average Equity (ROAE) and Return on Average Assets (ROAA) are on continuous improvement, compared to the first nine months of 2007. ROAE and ROAA reached 37and 3.25for YTD 2008 respectively.
Furthermore, CIB's equity base remained extremely solid, evidenced by a conservative Capital Adequacy Ratio (CAR) of 11.85% and an adjusted CAR (including YTD net profit) of 15%Such a base acts as a safety cushion to overcome any possible impact from the foreseen global economic downturn.

Asset quality, prudent credit culture and risk management best practice

NPL ratio significantly decreased to reach 2.49% down from 3% in FYE 2007, with provisions' coverage ratios of 207%, in compliance with, if not more than, the regulatory requirements. These provisions include EGP 839 million of general provisions covering the performing exposure, and the remaining provisions covers the Non-Performing portion of customers' exposure. Moreover, these requirements allow accounting for exposures' collaterals, a procedure that CIB conservatively avoid. In fact, CIB's conservative credit culture resulted in a well diversified loan book that minimizes earnings vulnerability at times of economic shocks.
It is worth-mentioning that due from foreign banks represents only 6% of the Bank's total assets, which are placed with sound banks that are not facing liquidity squeeze. In fact, CIB follows the approved risk management policies (by both the board and the CBE) in assets, liabilities and exposure allocation to avoid concentration risk. Moreover, CIB's internal policy is periodically reviewed especially in such critical times, accordingly preserving shareholders value. In addition, CIB has no exposure to US subprime mortgage related securities.

Asset efficiency and cost structure

Expenses grew b34% over same period last year, which was mainly attributed to the following:

Salary and benefits adjustments for staff packages and inflation.

Headcount increase predominantly on the retail side.

Significant investments in our distribution channels evidenced by the inauguration of an additional 18 outlets, 30 ATMs as well as 2,699 POS since Jan 2008.

Despite all these enhancements, our cost control strategies managed to maintain a cost to income ratio of 30.10%

Inspite of the increasing competition in the market, CIB managed to increase its Net Interest Margin (NIM) by 17.56compared to YTD Sep. 2007 to reach 3.84%as indication of the effective Balance Sheet Management.

 To view the graphs and the full announcement please click on the following link:

 http://www.rns-pdf.londonstockexchange.com/rns/0616I_1-2008-11-12.pdf

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGMMMMZNGRZZ
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.